Innovative Funding Models for Alzheimer's Disease & Dementia Research
One of the many highlights of our Alzheimer's Disease Summit: The Path to 2025, was the panel discussion focused on new and innovative funding models. Watch video highlights from that talk.
Published December 02, 2013
On November 6 and 7, global leaders from government, academia, NGOs, finance, and industry gathered to accelerate progress on Alzheimer's R&D at the "
Program
Alzheimer's Disease and Dementia Initiative
The Academy's Alzheimer's Disease and Dementia Initiative (ADDI) aims to accelerate T1 translation — the transfer of basic research about disease mechanisms into the development of new methods for diagnosis, treatment, and prevention — through an unprecedented multi-sector partnership focused on Alzheimer's disease and dementia.
Archived Event Information
Alzheimer's Disease Summit: The Path to 2025
November 6 - 7, 2013
A primary goal of this critical meeting was to convene leading industry, academic, and government stakeholders to actively participate in discussions regarding how to prevent and effectively treat Alzheimer's by 2025, by coordinating with governmental efforts to build research resources, reengineer current drug development and evaluation systems, and identify innovative technologies and financing models.